Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES)

Kneebone, Andrew; Fraser-Browne, Carol; Duchesne, Gillian M.; Fisher, Richard; Frydenberg, Mark; Herschtal, Alan; Williams, Scott G.; Brown, Chris; Delprado, Warick; Haworth, Annette; Joseph, David J.; Martin, Jarad M.; Matthews, John H.L.; Millar, Jeremy

(2020), LANCET ONCOL, 21(10), 1331-1340.

DOI: 10.1016/S1470-2045(20)30456-3

External Validation of a Predictive Model of Urethral Strictures for Prostate Patients Treated With HDR Brachytherapy Boost

Panettieri, Vanessa; Rancati, Tiziana; Onjukka, Eva; Ebert, Martin A.; Joseph, David J.; Denham, James W.; Steigler, Allison; Millar, Jeremy L.

(2020), FRONT ONCOL, 10, 910

DOI: 10.3389/fonc.2020.00910

Radiation oncology trainee research requirements – re-thinking our intention and approach

Ong, Wee Loon; Koh, Tze Lui; Udovicich, Cristian; Hanna, Gerrard G.; Ball, David; Millar, Jeremy; Foroudi, Farshad

(2020), J MED IMAG RADIAT ON, 64(3), 462-463

DOI: 10.1111/1754-9485.13022

Skin Mark-Free Less Patient Setup: A Physicist's Perspective

Panettieri V, Paul S, Russell C

(2020), In: Hosiak, Paxton, Waghorn, Pawlicki (eds). Surface Guided Radiation Therapy, 1st edition. Taylor and Francis, Boca Raton, Chapter 20,

DOI: 10.1201/9780429489402

Custom-designed Small Animal focal iRradiation Jig (SARJ): design, manufacture and dosimetric evaluation

Selvaraj J, Rhall G, Ibrahim M, Mahmood T, Freeman N, Gromek Z, Buchanan G, Syed F, Elsaleh H, Quah BJC

(2020), BJR Open, 2(1), 20190045

DOI: 10.1259/bjro.20190045

Nanoparticle dose enhancement of synchrotron radiation in PRESAGE dosimeters

Gagliardi FM, Franich RD, Geso M

(2020), J Synchrotron Radiat, 27(Pt 6), 1590-1600

DOI: 10.1107/S1600577520012849

Future directions of in vivo dosimetry for external beam radiotherapy and brachytherapy

Verhaegen F, Fonseca GP, Johansen JG, Beaulieu L, Beddar S, Greer P, Jornet N, Kertzscher G, McCurdy B, Smith RL, Mijnheer B, Olaciregui-Ruiz I, Tanderup K

(2020), Physics and Imaging in Radiation Oncology, 16, 18-9

DOI: 10.1016/j.phro.2020.09.001

In vivo dosimetry in brachytherapy: Requirements and future directions for research, development, and clinical practice

Fonseca GP, Johansen JG, Smith RL, Beaulieu L, Beddar S, Kertzscher G, Verhaegen F, Tanderup K

(2020), Physics and Imaging in Radiation Oncology, 16, 1-11

DOI: 10.1016/j.phro.2020.09.002

A Monte Carlo model of synchrotron radiotherapy shows good agreement with experimental dosimetry measurements: Data from the imaging and medical beamline at the Australian Synchrotron

Day LRJ, Pellicioli P, Gagliardi F, Barnes M, Smyth LML, Butler D, Livingstone J, Stevenson AW, Lye J, Poole CM, Hausermann D, Rogers PAW, Crosbie JC

(2020), PHYS MEDICA, 77, 64-74

DOI: 10.1016/j.ejmp.2020.07.017

The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs

Kouspou MM, Fong JE, Brew N, Hsiao STF, Davidson SL, Choyke PL, Crispino T, Jain S, Jenster GW, Knudsen BS, Millar JL, Mittmann N, Ryan CJ, Tombal B, Buzza M

(2020), Nat Rev Urol, 17(9), 499-512

DOI: 10.1038/s41585-020-0349-1

Voxel-level biological optimisation of prostate IMRT using patient-specific tumour location and clonogen density derived from mpMRI

Her EJ, Haworth A, Reynolds HM, Sun Y, Kennedy A, Panettieri V, Bangert M, Williams S, Ebert MA

(2020), Radiat Oncol, 15(1), 172

DOI: 10.1186/s13014-020-01568-6

Total body irradiation in Australia and New Zealand: results of a practice survey

Fog LS, Wirth A, MacManus M, Downes S, Grace M, Moggré A, Mugabe K, Neveri G, Nourbehesht L, Panettieri V, Pope D, Sim L, Stanton C, Steer B, Stewart A, Ungureanu E, Kron T

(2020), Physical and Engineering Sciences in Medicine, 43(3), 825-35

DOI: 10.1007/s13246-020-00878-z

Samarium doped titanium dioxide nanoparticles as theranostic agents in radiation therapy

Nakayama M, Smith CL, Feltis BN, Piva TJ, Tabatabaie F, Harty PD, Gagliardi FM, Platts K, Otto S, Blencowe A, Morita K, Geso M

(2020), PHYS MEDICA, 75, 69-76

DOI: 10.1016/j.ejmp.2020.06.007

A biochemical definition of cure after brachytherapy for prostate cancer

Crook JM, Tang C, Thames H, Blanchard P, Sanders J, Ciezki J, Keyes M, Morris WJ, Merrick G, Catton C, Raziee H, Stock R, Sullivan F, Anscher M, Millar J, Frank S

(2020), Radiother Oncol, 149, 64-9

DOI: 10.1016/j.radonc.2020.04.038

The Australian and New Zealand Thyroid Cancer Registry Annual Report, 2019

Ioannou L, Serpell J, Greenhill E, Bavor C, Hansen J, Earnest A, Miller J, Bendinelli C, Cope D, Glover A, Gough J, Harper S, Lee J, Lisewski D, Meyer-Rochow W, Millar J, Sidhu S, Sywak M, Topliss D, Walters D, Zalcberg J, Allnutt M, Bhatt C, Ahern S

(2020), Public Health and Preventive Medicine, Monash University, June 2020, Report No. 02.,

Are We Choosing Wisely in Radiation Oncology Practice–Findings From an Australian Population-Based Study

Ong, Wee Loon; Foroudi, Farshad; Milne, Roger L.; Millar, Jeremy L.

(2019), INT J RADIAT ONCOL, 104(5), 1012-1016.

DOI: 10.1016/j.ijrobp.2019.03.048

Quality of Life Outcomes After Stereotactic Ablative Radiation Therapy (SABR) Versus Standard of Care Treatments in the Oligometastatic Setting

Olson, Robert; Senan, Suresh; Harrow, Stephen; Gaede, Stewart; Louie, Alexander; Haasbeek, Cornelis; Mulroy, Liam; Lock, Michael; Rodrigues, George; Yaremko, Brian; Schellenberg, Devin; Ahmad, Belal; Griffioen, Gwendolyn; Senthi, Sashendra; Swaminath, Anand; Kopek, Neil; Liu, Mitchell; Moore, Karen; Currie, Suzanne; Bauman, Glenn; Warner, Andrew; Palma, David

(2019), INT J RADIAT ONCOL, 105(5), 943-947.

DOI: 10.1016/j.ijrobp.2019.08.041

Contrast enhanced oesophageal avoidance for stereotactic body radiotherapy: Barium vs. Gastrografin

Woodford K, Panettieri V, Ruben JD, Davis S, Sim E, Tran Le T, Senthi S

(2019), Tech Innov Patient Support Radiat Oncol, 12, 16-22

DOI: 10.1016/j.tipsro.2019.10.004

Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial

Palma DA, Olson R, Harrow S, Correa RJM, Schneiders F, Haasbeek CJA, Rodrigues GB, Lock M, Yaremko BP, Bauman GS, Ahmad B, Schellenberg D, Liu M, Gaede S, Laba J, Mulroy L, Senthi S, Louie AV, Swaminath A, Chalmers A, Warner A, Slotman BJ, de Gruijl TD, Allan A, Senan S

(2019), BMC Cancer, 19(1), 816

DOI: 10.1186/s12885-019-5977-6

Identifying optimal clinical scenarios for synchrotron microbeam radiation therapy: A treatment planning study

Smyth LML, Day LR, Woodford K, Rogers PAW, Crosbie JC, Senthi S

(2019), PHYS MEDICA, 60, 111-9

DOI: 10.1016/j.ejmp.2019.03.019

1 2 3 4 5